ODB Formulary

Ontario Drug Benefit Formulary

Veröffentlicht von: RxCoverage Canada

Beschreibung

Introducing the Ontario Drug Benefit (ODB) Formulary App. The Complete e-Formulary Database in the palm of your hand plus links to Health Canada-approved Product Monographs.
After the initial download & installation, the app is available for Offline use – access on the road, out and about, at point of care, etc. You will need internet access for the monthly formulary updates.
Web version of ODB Formulary app is also available at https://on.rxcoverage.ca/
Some of the key features:
•Simplified Search for Brand/Generic Name, Manufacturer, DIN/PIN/NPN
•One-click access to Product details – Therapeutic Notes, LU Clinical Criteria, Interchangeable Products, and more
•Easy to navigate by Generics, Therapeutic Classes, Benefit Categories, and Manufacturers.
•Instant information on over 5,000 drugs and other substances covered by Ontario drug benefit programs (including some nutrition products, diabetic testing agents, valved holding chambers and flash glucose monitoring systems).
•Synonyms for the Generic Names are searchable e.g., Cyclosporine vs Ciclosporin (INN), Cephalexin vs Cefalexin (INN), Pizotyline vs Pizotifen (INN), etc.
•Benefit Category column for prompt info on coverage status
•Interchangeability Check by DIN/PIN or Generic composition
•My Formulary feature enables you to build your own formulary by simply bookmarking your favourite medicines
•Access links to Health Canada-approved Product Monographs, etc.
DISCLAIMER:
The ODB Formulary App provides access to the Ontario Drug Benefit (ODB) Formulary database under a non-commercial license from Ontario's Ministry of Health & Long-Term Care. While we strive for accuracy and currency of the data, the app is to be used for information and educational purposes only. It is not intended as a complete replacement for the official provincial publications and should not be relied upon solely for final treatment decisions or claims adjudication. The app may not have real-time updates, and users are responsible for verifying information. Offline access may not guarantee continuous availability or data accuracy. The app may contain links to external resources; their content is beyond our control. We disclaim warranties and shall not be liable for any damages arising from app use. By using the app, users agree to indemnify and hold harmless the developers and Ontario's Ministry of Health & Long-Term Care. For all inquiries, please contact [email protected]
Ausblenden Mehr anzeigen...

Screenshots

ODB Formulary Häufige Fragen

  • Ist ODB Formulary kostenlos?

    Ja, ODB Formulary ist komplett kostenlos und enthält keine In-App-Käufe oder Abonnements.

  • Ist ODB Formulary seriös?

    Nicht genügend Bewertungen, um eine zuverlässige Einschätzung vorzunehmen. Die App benötigt mehr Nutzerfeedback.

    Danke für die Stimme

  • Wie viel kostet ODB Formulary?

    ODB Formulary ist kostenlos.

  • Wie hoch ist der Umsatz von ODB Formulary?

    Um geschätzte Einnahmen der ODB Formulary-App und weitere AppStore-Einblicke zu erhalten, können Sie sich bei der AppTail Mobile Analytics Platform anmelden.

Benutzerbewertung
Die App ist in Ecuador noch nicht bewertet.
Bewertungsverlauf

ODB Formulary Bewertungen

Keine Bewertungen in Ecuador
Die App hat noch keine Bewertungen in Ecuador.

Store-Rankings

Ranking-Verlauf
App-Ranking-Verlauf noch nicht verfügbar
Kategorien-Rankings
App ist noch nicht gerankt

ODB Formulary Installationen

Letzte 30 Tage

ODB Formulary Umsatz

Letzte 30 Tage

ODB Formulary Einnahmen und Downloads

Gewinnen Sie wertvolle Einblicke in die Leistung von ODB Formulary mit unserer Analytik.
Melden Sie sich jetzt an, um Zugriff auf Downloads, Einnahmen und mehr zu erhalten.
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.